TWIN CAPITAL MANAGEMENT INC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1059187 MCMURRAY, PA

Position in HALO

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$888,207

+$150,004 QoQ

Shares Held

11,348

-0.6% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#319

of 664 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TWIN CAPITAL MANAGEMENT INC holds $3,591,759 across 4 Biotechnology names. HALO ranks #3 (24.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	9,198	$1,042,685
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,836	$911,996
3	HALO	Halozyme Therapeutics, Inc. This page	11,348	$888,207
4	REGN	Regeneron Pharmaceuticals, Inc.	1,201	$748,871

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$888,207	11,348	-0.6%	Shares	Sole	2026-08-06
2026-03-31	$738,203	11,422	+1.4%	Shares	Sole	2026-05-05
2025-12-31	$757,865	11,261	—	Shares	Sole	2026-02-06
No filing history on record for this holder in this stock.